Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

All due respect to DaubersUP...no one else noticed the difference between the PR and the filing and if they did they didn't mention it...but I'm not sure that it was a "nice" find.
1. Moving from the PR's "any of the Company’s clinical assets" to the filing's "the Company’s Brilacidin compound in the indication of Oral Mucositis" may have added some specificity to our understanding of the agreement but in doing so it also eliminated all of the Company's other drugs/indications from qualifying for "$2 million upon announcement of the Company entering into a licensing arrangement with a pharmaceutical company for any of the Company’s clinical assets that will include an initial payment to the Company of an amount in the double-digits millions of dollars." That's not so nice.
2. At the moment of the filing the share price had already moved to $.48. "Clarifying" that the subject of the Fourth Purchase Shares was B-OM didn't result in a significant, lasting bump to the share price as one might have expected it to had the market appreciated the likelihood that a deal had been signaled as has been suggested here. It seems as if moneyed people who follow these things don't share in the enthusiasm for this nice find.